| Product Name | Ipragliflozin - API |
| Product Code | DA-I134-a |
| Chemical name | Ipragliflozin |
| Synonyms | (2S,3R,4R,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Suglat; (1S)-1,5-Anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol; |
| Impurity | NA |
| CAS Number | 761423-87-4 |
| Alternate CAS # | NA |
| Molecular form | C21H21FO5S |
| Appearance | White to Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 404.45 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Ipragliflozin is a potent and selective inhibitor of sodium-glucose cotransporter-2 (SGLT2) and can serve as a potential agent for the treatment of type 1 and type 2 diabetes. Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
